MAPT and tauopathy: The observation that SPD polyamination enhances pathogenic conformations while reducing filamentous aggregation is potentially significant given emerging evidence that tau oligomers and/or modified monomers, rather than filaments, are likely the primary drivers of neurotoxicity in tauopathies.